Smith & Nephew gets in on $19m Trice Medical Series C (MassDevice)
Trice Medical said today it closed a $19.3 million Series C financing round, joined by major player Smith & Nephew (NYSE:SNN), with funds slated to support US market penetration of its mi-eye2 orthopedic diagnostic device.
Newly invested Smith & Nephew was joined by Safeguard Scientifics, HealthQuest Capital, BioStar Ventures and other unnamed returning investors in the round. The U.K.-based company said it has raised $40.9 million to date.
“This is a significant milestone for Trice Medical as we looking to expand ...
The Orthopedics Industry 
